Fig. 1

Sevoflurane exposure inducing cognitive dysfunction. A, The schedule of the first experiment. B, The schematic diagram of the MWM test. C, The number of entering the platform quadrant of rats in the MWM test. D, The time spent in the platform quadrant of rats in the MWM test. E, The time spent in the platform quadrant of rats in the control group on the first day and third day after sevoflurane exposure. F, The number of entering the platform quadrant of rats in the control group on the first day and third day after sevoflurane exposure. G, The time spent in the platform quadrant of rats in the PND group on the first day and third day after sevoflurane exposure. H, The number of entering the platform quadrant of rats in the PND group on the first day and third day after sevoflurane exposure. Data are shown as mean ± SD (n = 8). ^*P < 0.05 or ^**P < 0.01.